Skip to main content
. 2018 May 25;361:k1452. doi: 10.1136/bmj.k1452

Table 2.

Scope of key policies for clinical trial reporting to ClinicalTrials.gov*

Policy (effective date) Scope/requirements
Registration Results reporting
Food and Drugs Administration Modernization Act (21 November 1997; ClinicalTrials.gov registry available starting on 29 February 2000) Clinical trials of investigational new drugs for serious or life threatening conditions and diseases N/A
International Committee of Medical Journal Editors8† (1 July 2005 for newly initiated trials; 13 September 2005 for ongoing trials) All clinical trials as a condition for consideration of publication of results As of December 2017: expected for clinical trials subject to the results reporting requirements of relevant funding and regulatory agencies, and encouraged for all other interventional studies.9
Food and Drugs Administration Amendments Act (FDAAA)10 (27 September 2007) Non-phase 1 clinical trials of FDA regulated drug and biological products, and non-feasibility trials of FDA regulated device products Non-phase 1 clinical trials of FDA approved/licensed drug and biological products, and non-feasibility trials of FDA cleared/approved device products
Final rule implementing FDAAA in Title 42, Part 11 of the Code of Federal Regulations (42 CFR Part 11) 11 (18 January 2017) Non-phase 1 clinical trials of FDA regulated drug and biological products, and non-feasibility trials of FDA regulated device products Non-phase 1 clinical trials of FDA regulated drug and biological products, and non-feasibility trials of FDA regulated device products, whether or not FDA approved, cleared, or licensed
NIH policy on the dissemination of NIH funded clinical trial information12 (18 January 2017) Clinical trials funded by the NIH Clinical trials funded by the NIH

N/A=not applicable; NIH=National Institutes of Health.

*

For a more complete listing, see table in Selected Trial Registration Laws and Policies (https://clinicaltrials.gov/ct2/manage-recs/background#WhyRegister).

Requires registration at ClinicalTrials.gov, or one of the primary registries on the WHO International Clinical Trials Registry Platform (http://www.who.int/ictrp/network/primary/en/).